These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 9174606)

  • 21. Qa-2 molecules are peptide receptors of higher stringency than ordinary class I molecules.
    Rötzschke O; Falk K; Stevanović S; Grahovac B; Soloski MJ; Jung G; Rammensee HG
    Nature; 1993 Feb; 361(6413):642-4. PubMed ID: 8437623
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Natural killer cell recognition of HLA class I molecules.
    Brooks AG; Boyington JC; Sun PD
    Rev Immunogenet; 2000; 2(3):433-48. PubMed ID: 11256749
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Peptide binding characteristics of the non-classical class Ib MHC molecule HLA-E assessed by a recombinant random peptide approach.
    Stevens J; Joly E; Trowsdale J; Butcher GW
    BMC Immunol; 2001; 2():5. PubMed ID: 11432755
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gorillas with spondyloarthropathies express an MHC class I molecule with only limited sequence similarity to HLA-B27 that binds peptides with arginine at P2.
    Urvater JA; Hickman H; Dzuris JL; Prilliman K; Allen TM; Schwartz KJ; Lorentzen D; Shufflebotham C; Collins EJ; Neiffer DL; Raphael B; Hildebrand W; Sette A; Watkins DI
    J Immunol; 2001 Mar; 166(5):3334-44. PubMed ID: 11207289
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Peptide Binding to HLA-E Molecules in Humans, Nonhuman Primates, and Mice Reveals Unique Binding Peptides but Remarkably Conserved Anchor Residues.
    Ruibal P; Franken KLMC; van Meijgaarden KE; van Loon JJF; van der Steen D; Heemskerk MHM; Ottenhoff THM; Joosten SA
    J Immunol; 2020 Nov; 205(10):2861-2872. PubMed ID: 33020145
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structural features impose tight peptide binding specificity in the nonclassical MHC molecule HLA-E.
    O'Callaghan CA; Tormo J; Willcox BE; Braud VM; Jakobsen BK; Stuart DI; McMichael AJ; Bell JI; Jones EY
    Mol Cell; 1998 Mar; 1(4):531-41. PubMed ID: 9660937
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of five different Patr class I molecules that bind HLA supertype peptides and definition of their peptide binding motifs.
    McKinney DM; Erickson AL; Walker CM; Thimme R; Chisari FV; Sidney J; Sette A
    J Immunol; 2000 Oct; 165(8):4414-22. PubMed ID: 11035079
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A peptide from heat shock protein 60 is the dominant peptide bound to Qa-1 in the absence of the MHC class Ia leader sequence peptide Qdm.
    Davies A; Kalb S; Liang B; Aldrich CJ; Lemonnier FA; Jiang H; Cotter R; Soloski MJ
    J Immunol; 2003 May; 170(10):5027-33. PubMed ID: 12734347
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Peptide motifs of closely related HLA class I molecules encompass substantial differences.
    Rötzschke O; Falk K; Stevanović S; Jung G; Rammensee HG
    Eur J Immunol; 1992 Sep; 22(9):2453-6. PubMed ID: 1516632
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structure and function of the human MHC class Ib molecules HLA-E, HLA-F and HLA-G.
    O'Callaghan CA; Bell JI
    Immunol Rev; 1998 Jun; 163():129-38. PubMed ID: 9700506
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Peptide binding to the class Ib molecule, Qa-1b.
    Kurepa Z; Forman J
    J Immunol; 1997 Apr; 158(7):3244-51. PubMed ID: 9120280
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HLA-E surface expression depends on binding of TAP-dependent peptides derived from certain HLA class I signal sequences.
    Lee N; Goodlett DR; Ishitani A; Marquardt H; Geraghty DE
    J Immunol; 1998 May; 160(10):4951-60. PubMed ID: 9590243
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HLA-F is a predominantly empty, intracellular, TAP-associated MHC class Ib protein with a restricted expression pattern.
    Wainwright SD; Biro PA; Holmes CH
    J Immunol; 2000 Jan; 164(1):319-28. PubMed ID: 10605026
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HLA-E: a novel player for histocompatibility.
    Kraemer T; Blasczyk R; Bade-Doeding C
    J Immunol Res; 2014; 2014():352160. PubMed ID: 25401109
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The murine liver-specific nonclassical MHC class I molecule Q10 binds a classical peptide repertoire.
    Zappacosta F; Tabaczewski P; Parker KC; Coligan JE; Stroynowski I
    J Immunol; 2000 Feb; 164(4):1906-15. PubMed ID: 10657640
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Peptide binding to HLA class I molecules: homogenous, high-throughput screening, and affinity assays.
    Harndahl M; Justesen S; Lamberth K; Røder G; Nielsen M; Buus S
    J Biomol Screen; 2009 Feb; 14(2):173-80. PubMed ID: 19196700
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The structure and stability of the monomorphic HLA-G are influenced by the nature of the bound peptide.
    Walpole NG; Kjer-Nielsen L; Kostenko L; McCluskey J; Brooks AG; Rossjohn J; Clements CS
    J Mol Biol; 2010 Mar; 397(2):467-80. PubMed ID: 20122941
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antigen presentation by major histocompatibility complex class I-B molecules.
    Shawar SM; Vyas JM; Rodgers JR; Rich RR
    Annu Rev Immunol; 1994; 12():839-80. PubMed ID: 8011299
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A nonpolymorphic major histocompatibility complex class Ib molecule binds a large array of diverse self-peptides.
    Joyce S; Tabaczewski P; Angeletti RH; Nathenson SG; Stroynowski I
    J Exp Med; 1994 Feb; 179(2):579-88. PubMed ID: 8294869
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ensemble approaches for improving HLA class I-peptide binding prediction.
    Hu X; Mamitsuka H; Zhu S
    J Immunol Methods; 2011 Nov; 374(1-2):47-52. PubMed ID: 20849860
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.